Efficacy Evaluation of Meloxicam 15mg Tablet through Bioequivalence Study in Indonesian Healthy Volunteers
Journal Title: Open Access Journal of Pharmaceutical Research - Year 2024, Vol 8, Issue 1
Abstract
Objective: The objective of this study is to compare the efficacy between the generic drug of Meloxicam 15mg Tablets produced by PT. Kimia Farma Tbk and its comparator (Movi-Cox® 15mg Tablet by PT. Boehringer Ingelheim Indonesia) by a study of bioequivalence in Indonesian healthy volunteers Methods: A randomized, single-dose, open-label, crossover two-way (2 treatments, 2 periods, and 2 sequences) under fasting condition were conducted in healthy Indonesian volunteers to evaluate bioequivalence between 2 formulations of Meloxicam 15mg tablet. This study required washout period of at least 7-days. The test and comparator drug were administered to subjects as a single oral dose. Blood samples were collected adequately (0–72 h) with 18 points to determine meloxicam concentrations in plasma using a validated LC-MS/MS analytical method. The number of subjects who participated and completed the study were 18 volunteer (9 male and 9 female). The pharmacokinetic parameters calculated in this study are AUC0-72, AUC0-inf, Cmax, tmax, and t½. The bioequivalence acceptance limit of 90% confidence interval (CI) with α = 5.00% is 80.00–125.00% for AUC and Cmax parameters. The estimation of Tmax and T½ in the bioequivalence study was based on a nonparametric statistical procedure on the original data using Wilcoxon Sign Test. Result: The results for AUC0-72 and Cmax were 108.07% (104.88-111.35) % and 105.24% (97.72-113.34) % respectively with intra-subject variability (%CV) was 5.15% for AUC0-t and 12.80% for Cmax. These results were within the regulatory acceptance limit 80.00-125.00%. Conclusion: Based on this result, it was concluded that the test formulation is bioequivalent to comparator formulation.
Authors and Affiliations
Priyanto*, Widiastuti E, Wahyono BH, Susilo MJ, Yunica NT, Bachtiar LNW, Anindyani SA, Azzaera AH and Wahyuningsih R
Keywords
Related Articles
- EP ID EP751874
- DOI 10.23880/oajpr-16000304
- Views 20
- Downloads 0
Density Functional Study of Aflatoxin B1, B2, G1 and G2: NBO and AIM Analyses
Aflatoxin, belonging to the bisfuranocoumarine group of organic compounds, encompasses several species such as aflatoxin B1, B2, G1, and G2. In this study, geometry optimizations of these aflatoxins were conducted using...
Cannabinoid Receptor CB2 Subtype: A Novel Pharmacological Target in Cancer and Neurodegenerative Diseases
CB2 receptor (CB2R) is one of the canonical cannabinoid receptor belonging to endocannabinoid system (ECS). It was cloned for the first time in 1993 from the human leukemia cell line HL-60, and it is part of the G-protei...
Formulation Development and Evaluation of Mouth Dissolving Film of Taurine and Their Future Perspectives
This study focuses on the formulation development and evaluation of mouth dissolving films (MDFs) containing taurine, an amino acid with potential therapeutic benefits. Taurine-loaded MDFs were formulated using hydroxyp...
Cloud Computing and Biological Data
The diversity of data leads to volume, velocity, variety, variability and value, the “V”s of big data worldwide known. And these are the challenges for biomedical and data scientists to bring proper information out of th...
Pharmacy Education in Egypt
Egypt is a developing nation that occupies an important geographic and historic position in the heart of the Middle East. It is located in the cross roads between Africa, Asia and Europe. Its population is approximately...